Literature DB >> 16635684

Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimod.

Josephine A Taverna, Catherine M Stefanato, Frederick D Wax, Marie-France Demierre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16635684     DOI： 10.1016/j.jaad.2006.01.061

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.

Authors:  Antona J Wagstaff; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.

Authors:  Samir Dalia; Michael Jaglal; Paul Chervenick; Hernani Cualing; Lubomir Sokol
Journal:  Cancers (Basel)       Date:  2014-11-14       Impact factor: 6.639

3.  Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient.

Authors:  Shinsaku Imashuku; Miyako Kobayashi; Yoichi Nishii; Keisuke Nishimura
Journal:  Case Rep Dermatol Med       Date:  2018-01-03

4.  Advances in the use of topical imiquimod to treat dermatologic disorders.

Authors:  Francesco Lacarrubba; Maria Rita Nasca; Giuseppe Micali
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.